Erin Cameron
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Erin Cameron has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
- Linda Rabeneck
University of Toronto
1 shared publication - Mohammad Z. Haque
Prevention & Cancer Control, Ontario Health (Cancer Care Ontario), Toronto, ON M5G 2L3, Canada
1 shared publication - Naomi Schwartz
Prevention & Cancer Control, Ontario Health (Cancer Care Ontario), Toronto, ON M5G 2L3, Canada
1 shared publication - Rebecca Truscott
Prevention & Cancer Control, Ontario Health (Cancer Care Ontario), Toronto, ON M5G 2L3, Canada
1 shared publication - Sahara Khan
Prevention & Cancer Control, Ontario Health (Cancer Care Ontario), Toronto, ON M5G 2L3, Canada
1 shared publication - Sargam Rana
Prevention & Cancer Control, Ontario Health (Cancer Care Ontario), Toronto, ON M5G 2L3, Canada
1 shared publication
Latest Publications
- Open Access
- 30 June 2022
- Published by MDPI AG in Current Oncology
- Vol. 29 (7) , 4604-4611
Evolution of a Systematic Approach to Smoking Cessation in Ontario’s Regional Cancer Centres
Smoking cessation after a cancer diagnosis can significantly improve a person’s prognosis, treatment efficacy and safety, and quality of life. In 2012, Cancer Care Ontario (now part of Ontario Health) introduced a Framework for Smoking Cessation, to be implemented for new ambulatory cancer patients at the province’s 14 Regional Cancer Centres (RCCs). Over time, the program has evolved to become more efficient, use data for robust performance management, and broaden its focus to include new patient populations and additional data collection. In 2017, the framework was revised from a 5As to a 3As brief intervention model, along with an opt-out approach to referrals. The revised model was based on emerging evidence, feedback from stakeholders, and an interim program evaluation. Results showed an initial increase in referrals to cessation services. Two indicators (tobacco use screening and acceptance of a referral) are routinely monitored as part of Ontario Health’s system-wide performance management approach, which has been identified as a key driver of change among RCCs. Due to the COVID-19 pandemic, many RCCs reported a decrease in these indicators. RCCs that were able to maintain a high level of smoking cessation activities during the pandemic offer valuable lessons, including the opportunity to swiftly leverage virtual care. Future directions for the program include capturing data on cessation outcomes and expanding the intervention to new populations. A focus on system recovery from COVID-19 will be paramount. Smoking cessation must remain a core element of high-quality cancer care, so that patients achieve the best possible health benefits from their treatments.
- 30 June 2022
- Published by MDPI AG in Current Oncology
- Vol. 29 (7) , 4604-4611
Open AccessEvolution of a Systematic Approach to Smoking Cessation in Ontario’s Regional Cancer Centres
Smoking cessation after a cancer diagnosis can significantly improve a person’s prognosis, treatment efficacy and safety, and quality of life. In 2012, Cancer Care Ontario (now part of Ontario Health) introduced a Framework for Smoking Cessation, to be implemented for new ambulatory cancer patients at the province’s 14 Regional Cancer Centres (RCCs). Over time, the program has evolved to become more efficient, use data for robust performance management, and broaden its focus to include new patient populations and additional data collection. In 2017, the framework was revised from a 5As to a 3As brief intervention model, along with an opt-out approach to referrals. The revised model was based on emerging evidence, feedback from stakeholders, and an interim program evaluation. Results showed an initial increase in referrals to cessation services. Two indicators (tobacco use screening and acceptance of a referral) are routinely monitored as part of Ontario Health’s system-wide performance management approach, which has been identified as a key driver of change among RCCs. Due to the COVID-19 pandemic, many RCCs reported a decrease in these indicators. RCCs that were able to maintain a high level of smoking cessation activities during the pandemic offer valuable lessons, including the opportunity to swiftly leverage virtual care. Future directions for the program include capturing data on cessation outcomes and expanding the intervention to new populations. A focus on system recovery from COVID-19 will be paramount. Smoking cessation must remain a core element of high-quality cancer care, so that patients achieve the best possible health benefits from their treatments.